Ethics and Oversight in Biotechnology: An Analysis of J. Levin's Program

The text analyzes the key role of the supervisory board in the biotechnology sector, arguing that it cannot be merely a facade of prestige but must function as an 'institutional conscience.' The author contrasts passive observers with active guardians who verify the reliability of research and the alignment of strategy with biological and moral reality. It emphasizes the necessity for the board to possess real scientific, regulatory, and ethical competencies to avoid the 'narrative hypnosis' of management. True oversight requires breaking through rituals of professionalism in favor of critical questions about the quality of clinical evidence, transparency in relations with regulators, and the real impact of business decisions on patient health and public trust in science.